-
1 Comment
Tongfang Kontafarma Holdings Limited is currently in a long term uptrend where the price is trading 5.8% above its 200 day moving average.
From a valuation standpoint, the stock is 85.7% cheaper than other stocks from the Basic Materials sector with a price to sales ratio of 0.2.
Tongfang Kontafarma Holdings Limited's total revenue rose by 301.5% to $711M since the same quarter in the previous year.
Its net income has dropped by 180.0% to $-49M since the same quarter in the previous year.
Finally, its free cash flow grew by 209.0% to $80M since the same quarter in the previous year.
Based on the above factors, Tongfang Kontafarma Holdings Limited gets an overall score of 4/5.
| Sector | Healthcare |
|---|---|
| Industry | Drug Manufacturers - Specialty & Generic |
| Exchange | HK |
| CurrencyCode | HKD |
| ISIN | KYG8918D1088 |
| Market Cap | 151M |
|---|---|
| Target Price | None |
| Beta | 0.3 |
| PE Ratio | None |
| Dividend Yield | None |
Kontafarma China Holdings Limited, an investment holding company, manufactures and sells chemical drugs, active pharmaceutical ingredients (API), and API intermediate in Mainland China, Singapore, Taiwan, and internationally. It operates through Pharmaceutical Business and Fitness Business segments. The company offers prescription drugs, including chemical drugs and prescribed traditional Chinese medicines; operates fitness and yoga centers, as well as franchise business; and provides management and consultation services for fitness and health activities. It also offers corporate advisory services; and researches and develops medical products. The company was formerly known as Tongfang Kontafarma Holdings Limited and changed its name to Kontafarma China Holdings Limited in September 2022. The company was incorporated in 2011 and is headquartered in Wan Chai, Hong Kong. Kontafarma China Holdings Limited is a subsidiary of China Health Management Investment Limited.
Learn MoreHere's how to backtest a trading strategy or backtest a portfolio for 1312.HK using our backtest tool. PyInvesting provides the backtesting software for you to backtest your investment strategy. Our backtest software is written using Python code and allows you to backtest stock, backtest etf, backtest options, backtest crypto and backtest forex online. Our backtesting Python framework is highly robust and gives you a realistic simulation of how your strategy would have performed in the past using backtest data.
© PyInvesting 2025
